These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23039905)

  • 21. Women's values and preferences and health state valuations for thromboprophylaxis during pregnancy: A cross-sectional interview.
    Bates SM; Alonso-Coello P; Tikkinen KA; Ebrahim S; Lopes LC; McDonald SD; Zhou Q; Akl EA; Neumann I; Jacobsen AF; Zhang Y; Santamaría A; Annichino-Bizzacchi JM; Sandset PM; Bitar W; Eckman MH; Guyatt GH
    Thromb Res; 2016 Apr; 140():22-9. PubMed ID: 27500301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Continuation of Low-Molecular-Weight Heparin versus Switching to Unfractionated Heparin in the Peripartum.
    Enakpene CA; Pontarelli KN; Della Torre M
    Am J Perinatol; 2020 Feb; 37(3):304-312. PubMed ID: 30818404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Where do we go now with low molecular weight heparin use in obstetric care?
    Patel JP; Hunt BJ
    J Thromb Haemost; 2008 Sep; 6(9):1461-7. PubMed ID: 18532999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case series of LMWH use in pregnancy: should trough anti-Xa levels guide dosing?
    Berresheim M; Wilkie J; Nerenberg KA; Ibrahim Q; Bungard TJ
    Thromb Res; 2014 Dec; 134(6):1234-40. PubMed ID: 25450535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged low-molecular-weight heparin use during pregnancy and subsequent bone mineral density.
    Galambosi P; Hiilesmaa V; Ulander VM; Laitinen L; Tiitinen A; Kaaja R
    Thromb Res; 2016 Jul; 143():122-6. PubMed ID: 27236710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of low-molecular-weight heparin during pregnancy: a retrospective controlled cohort study.
    Galambosi PJ; Kaaja RJ; Stefanovic V; Ulander VM
    Eur J Obstet Gynecol Reprod Biol; 2012 Aug; 163(2):154-9. PubMed ID: 22658765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: a case series.
    Rodie VA; Thomson AJ; Stewart FM; Quinn AJ; Walker ID; Greer IA
    BJOG; 2002 Sep; 109(9):1020-4. PubMed ID: 12269676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Women's values and preferences on low-molecular-weight heparin and pregnancy: a mixed-methods systematic review.
    León-García M; Humphries B; Maraboto A; Rabassa M; Boehmer KR; Perestelo-Perez L; Xie F; Pelayo I; Eckman M; Bates S; Selva A; Alonso-Coello P
    BMC Pregnancy Childbirth; 2022 Oct; 22(1):747. PubMed ID: 36199014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison Between Non-vitamin K Antagonist Oral Anticoagulants and Low-Molecular-Weight Heparin in Asian Individuals With Cancer-Associated Venous Thromboembolism.
    Chen DY; Tseng CN; Hsieh MJ; Lan WC; Chuang CK; Pang ST; Chen SW; Chen TH; Chang SH; Hsieh IC; Chu PH; Wen MS; Chen JS; Chang JW; See LC; Huang WK
    JAMA Netw Open; 2021 Feb; 4(2):e2036304. PubMed ID: 33533929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of Saudi Women's Adherence and Experience with Venous Thromboembolism Prophylaxis after Cesarean Section Delivery Using Telemedicine Technology.
    Elmaghraby DA; Al-Bassri ZK; AlTuraiki ZA; Alsaleh JA; Alzuwayyid LS; Albanyan NA; Almulhim AS
    Appl Bionics Biomech; 2022; 2022():8440789. PubMed ID: 35321355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients.
    Gonda DD; Fridley J; Ryan SL; Briceño V; Lam SK; Luerssen TG; Jea A
    J Neurosurg Pediatr; 2015 Sep; 16(3):329-34. PubMed ID: 26067336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in thrombin generation and D-dimer concentrations in women injecting enoxaparin during pregnancy and the puerperium.
    Patel JP; Patel RK; Roberts LN; Marsh MS; Green B; Davies JG; Arya R
    BMC Pregnancy Childbirth; 2014 Nov; 14():384. PubMed ID: 25406658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of low molecular weight heparin for prophylaxis and treatment of thromboembolism in pregnancy.
    Gillis S; Shushan A; Eldor A
    Int J Gynaecol Obstet; 1992 Dec; 39(4):297-301. PubMed ID: 1361463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-molecular-weight heparins for cancer-associated thrombosis: Adherence to clinical practice guidelines and patient perception in TROPIQUE, a 409-patient prospective observational study.
    Cajfinger F; Debourdeau P; Lamblin A; Benatar V; Falvo N; Benhamou Y; Sevestre MA; Farge-Bancel D;
    Thromb Res; 2016 Aug; 144():85-92. PubMed ID: 27318244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of adjusted-dose enoxaparin in pregnant patients with increased risk for venous thromboembolic disease.
    Bailly J; Jacobson BF; Louw S
    Int J Gynaecol Obstet; 2019 Apr; 145(1):70-75. PubMed ID: 30671924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low molecular weight heparin in pregnancy: current issues.
    Greer I; Hunt BJ
    Br J Haematol; 2005 Mar; 128(5):593-601. PubMed ID: 15725079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis.
    Gonzalez-Fajardo JA; Arreba E; Castrodeza J; Perez JL; Fernandez L; Agundez I; Mateo AM; Carrera S; Gutiérrez V; Vaquero C
    J Vasc Surg; 1999 Aug; 30(2):283-92. PubMed ID: 10436448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-discharge adherence with venous thromboembolism prophylaxis after orthopedic trauma: Results from a randomized controlled trial of aspirin versus low molecular weight heparin.
    Haac BE; Van Besien R; O'Hara NN; Slobogean GP; Manson TT; O'Toole RV; Johal H; Berger PZ; Reahl GB; Marinos D; Degani Y; Mascarenhas D; Connelly D; Scalea TM; Stein DM
    J Trauma Acute Care Surg; 2018 Apr; 84(4):564-574. PubMed ID: 29251700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.
    de Jong PG; Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD004734. PubMed ID: 24995856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How I treat pregnancy-related venous thromboembolism.
    Middeldorp S
    Blood; 2011 Nov; 118(20):5394-400. PubMed ID: 21921048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.